drugset / Trial / NCT01968915
Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate safety and tolerability to estimate the maximum tolerated dose and/or recommended dose of oral LCL161 in Japanese patients with advanced solid tumors.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCL161 | Small molecule | — | Oral |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |